Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Growth (Status and Outlook) 2025-2031

September 2025 | 81 pages | ID: G7F90464CE17EN
LP Information

Abstracts

According to this study, the global Chronic Obstructive Pulmonary Disease (COPD) Treatment market size will reach US$ 16660 million by 2031.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Chronic Obstructive Pulmonary Disease (COPD) Treatment Industry Forecast” looks at past sales and reviews total world Chronic Obstructive Pulmonary Disease (COPD) Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Chronic Obstructive Pulmonary Disease (COPD) Treatment sales for 2025 through 2031. With Chronic Obstructive Pulmonary Disease (COPD) Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chronic Obstructive Pulmonary Disease (COPD) Treatment industry.

This Insight Report provides a comprehensive analysis of the global Chronic Obstructive Pulmonary Disease (COPD) Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Chronic Obstructive Pulmonary Disease (COPD) Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Chronic Obstructive Pulmonary Disease (COPD) Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chronic Obstructive Pulmonary Disease (COPD) Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chronic Obstructive Pulmonary Disease (COPD) Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Chronic Obstructive Pulmonary Disease (COPD) Treatment market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Corticosteroids
• Phosphodiesterase Type 4 Inhibitors
• Bronchodilators
• Others

Segmentation by Application:

• Hospital
• Clinic
• Retail Pharmacies
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• AstraZeneca
• Boehringer Ingelheim International GmbH
• GlaxoSmithKline
• Novartis AG
• Teva Pharmaceutical Industries
• Sunovion Pharmaceuticals
• CHIESI Farmaceutici
• Orion Corporation
• ?Mylan

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2020-2031)
  2.1.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Chronic Obstructive Pulmonary Disease (COPD) Treatment by Country/Region (2020, 2024 & 2031)
2.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Segment by Type
  2.2.1 Corticosteroids
  2.2.2 Phosphodiesterase Type 4 Inhibitors
  2.2.3 Bronchodilators
  2.2.4 Others
2.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type
  2.3.1 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Market Share by Type (2020-2025)
2.4 Chronic Obstructive Pulmonary Disease (COPD) Treatment Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Retail Pharmacies
  2.4.4 Other
2.5 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application
  2.5.1 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Market Share by Application (2020-2025)

3 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) TREATMENT MARKET SIZE BY PLAYER

3.1 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Market Share by Player
  3.1.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue by Player (2020-2025)
  3.1.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) TREATMENT BY REGION

4.1 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Region (2020-2025)
4.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth (2020-2025)
4.4 APAC Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth (2020-2025)
4.5 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2020-2025)
5.2 Americas Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2020-2025)
5.3 Americas Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Region (2020-2025)
6.2 APAC Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2020-2025)
6.3 APAC Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2020-2025)
7.2 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2020-2025)
7.3 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment by Region (2020-2025)
8.2 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2020-2025)
8.3 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) TREATMENT MARKET FORECAST

10.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecast by Region (2026-2031)
  10.1.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecast by Region (2026-2031)
  10.1.2 Americas Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecast
  10.1.3 APAC Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecast
  10.1.4 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecast
  10.1.5 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecast
10.2 Americas Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecast by Country (2026-2031)
  10.2.1 United States Market Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecast
  10.2.2 Canada Market Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecast
  10.2.3 Mexico Market Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecast
  10.2.4 Brazil Market Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecast
10.3 APAC Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecast by Region (2026-2031)
  10.3.1 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Forecast
  10.3.2 Japan Market Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecast
  10.3.3 Korea Market Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecast
  10.3.4 Southeast Asia Market Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecast
  10.3.5 India Market Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecast
  10.3.6 Australia Market Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecast
10.4 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecast by Country (2026-2031)
  10.4.1 Germany Market Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecast
  10.4.2 France Market Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecast
  10.4.3 UK Market Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecast
  10.4.4 Italy Market Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecast
  10.4.5 Russia Market Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecast
10.5 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecast by Region (2026-2031)
  10.5.1 Egypt Market Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecast
  10.5.2 South Africa Market Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecast
  10.5.3 Israel Market Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecast
  10.5.4 Turkey Market Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecast
10.6 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecast by Type (2026-2031)
10.7 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecast

11 KEY PLAYERS ANALYSIS

11.1 AstraZeneca
  11.1.1 AstraZeneca Company Information
  11.1.2 AstraZeneca Chronic Obstructive Pulmonary Disease (COPD) Treatment Product Offered
  11.1.3 AstraZeneca Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 AstraZeneca Main Business Overview
  11.1.5 AstraZeneca Latest Developments
11.2 Boehringer Ingelheim International GmbH
  11.2.1 Boehringer Ingelheim International GmbH Company Information
  11.2.2 Boehringer Ingelheim International GmbH Chronic Obstructive Pulmonary Disease (COPD) Treatment Product Offered
  11.2.3 Boehringer Ingelheim International GmbH Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Boehringer Ingelheim International GmbH Main Business Overview
  11.2.5 Boehringer Ingelheim International GmbH Latest Developments
11.3 GlaxoSmithKline
  11.3.1 GlaxoSmithKline Company Information
  11.3.2 GlaxoSmithKline Chronic Obstructive Pulmonary Disease (COPD) Treatment Product Offered
  11.3.3 GlaxoSmithKline Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 GlaxoSmithKline Main Business Overview
  11.3.5 GlaxoSmithKline Latest Developments
11.4 Novartis AG
  11.4.1 Novartis AG Company Information
  11.4.2 Novartis AG Chronic Obstructive Pulmonary Disease (COPD) Treatment Product Offered
  11.4.3 Novartis AG Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Novartis AG Main Business Overview
  11.4.5 Novartis AG Latest Developments
11.5 Teva Pharmaceutical Industries
  11.5.1 Teva Pharmaceutical Industries Company Information
  11.5.2 Teva Pharmaceutical Industries Chronic Obstructive Pulmonary Disease (COPD) Treatment Product Offered
  11.5.3 Teva Pharmaceutical Industries Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Teva Pharmaceutical Industries Main Business Overview
  11.5.5 Teva Pharmaceutical Industries Latest Developments
11.6 Sunovion Pharmaceuticals
  11.6.1 Sunovion Pharmaceuticals Company Information
  11.6.2 Sunovion Pharmaceuticals Chronic Obstructive Pulmonary Disease (COPD) Treatment Product Offered
  11.6.3 Sunovion Pharmaceuticals Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Sunovion Pharmaceuticals Main Business Overview
  11.6.5 Sunovion Pharmaceuticals Latest Developments
11.7 CHIESI Farmaceutici
  11.7.1 CHIESI Farmaceutici Company Information
  11.7.2 CHIESI Farmaceutici Chronic Obstructive Pulmonary Disease (COPD) Treatment Product Offered
  11.7.3 CHIESI Farmaceutici Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 CHIESI Farmaceutici Main Business Overview
  11.7.5 CHIESI Farmaceutici Latest Developments
11.8 Orion Corporation
  11.8.1 Orion Corporation Company Information
  11.8.2 Orion Corporation Chronic Obstructive Pulmonary Disease (COPD) Treatment Product Offered
  11.8.3 Orion Corporation Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Orion Corporation Main Business Overview
  11.8.5 Orion Corporation Latest Developments
11.9 ?Mylan
  11.9.1 ?Mylan Company Information
  11.9.2 ?Mylan Chronic Obstructive Pulmonary Disease (COPD) Treatment Product Offered
  11.9.3 ?Mylan Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 ?Mylan Main Business Overview
  11.9.5 ?Mylan Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Chronic Obstructive Pulmonary Disease (COPD) Treatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Corticosteroids
Table 4. Major Players of Phosphodiesterase Type 4 Inhibitors
Table 5. Major Players of Bronchodilators
Table 6. Major Players of Others
Table 7. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Market Share by Type (2020-2025)
Table 10. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Market Share by Application (2020-2025)
Table 13. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Market Share by Player (2020-2025)
Table 15. Chronic Obstructive Pulmonary Disease (COPD) Treatment Key Players Head office and Products Offered
Table 16. Chronic Obstructive Pulmonary Disease (COPD) Treatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Market Share by Region (2020-2025)
Table 21. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Market Share by Country (2020-2025)
Table 25. Americas Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Market Share by Type (2020-2025)
Table 27. Americas Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Market Share by Application (2020-2025)
Table 29. APAC Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Market Share by Region (2020-2025)
Table 31. APAC Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Market Share by Country (2020-2025)
Table 35. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Chronic Obstructive Pulmonary Disease (COPD) Treatment
Table 41. Key Market Challenges & Risks of Chronic Obstructive Pulmonary Disease (COPD) Treatment
Table 42. Key Industry Trends of Chronic Obstructive Pulmonary Disease (COPD) Treatment
Table 43. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. AstraZeneca Details, Company Type, Chronic Obstructive Pulmonary Disease (COPD) Treatment Area Served and Its Competitors
Table 48. AstraZeneca Chronic Obstructive Pulmonary Disease (COPD) Treatment Product Offered
Table 49. AstraZeneca Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. AstraZeneca Main Business
Table 51. AstraZeneca Latest Developments
Table 52. Boehringer Ingelheim International GmbH Details, Company Type, Chronic Obstructive Pulmonary Disease (COPD) Treatment Area Served and Its Competitors
Table 53. Boehringer Ingelheim International GmbH Chronic Obstructive Pulmonary Disease (COPD) Treatment Product Offered
Table 54. Boehringer Ingelheim International GmbH Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Boehringer Ingelheim International GmbH Main Business
Table 56. Boehringer Ingelheim International GmbH Latest Developments
Table 57. GlaxoSmithKline Details, Company Type, Chronic Obstructive Pulmonary Disease (COPD) Treatment Area Served and Its Competitors
Table 58. GlaxoSmithKline Chronic Obstructive Pulmonary Disease (COPD) Treatment Product Offered
Table 59. GlaxoSmithKline Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. GlaxoSmithKline Main Business
Table 61. GlaxoSmithKline Latest Developments
Table 62. Novartis AG Details, Company Type, Chronic Obstructive Pulmonary Disease (COPD) Treatment Area Served and Its Competitors
Table 63. Novartis AG Chronic Obstructive Pulmonary Disease (COPD) Treatment Product Offered
Table 64. Novartis AG Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Novartis AG Main Business
Table 66. Novartis AG Latest Developments
Table 67. Teva Pharmaceutical Industries Details, Company Type, Chronic Obstructive Pulmonary Disease (COPD) Treatment Area Served and Its Competitors
Table 68. Teva Pharmaceutical Industries Chronic Obstructive Pulmonary Disease (COPD) Treatment Product Offered
Table 69. Teva Pharmaceutical Industries Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Teva Pharmaceutical Industries Main Business
Table 71. Teva Pharmaceutical Industries Latest Developments
Table 72. Sunovion Pharmaceuticals Details, Company Type, Chronic Obstructive Pulmonary Disease (COPD) Treatment Area Served and Its Competitors
Table 73. Sunovion Pharmaceuticals Chronic Obstructive Pulmonary Disease (COPD) Treatment Product Offered
Table 74. Sunovion Pharmaceuticals Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. Sunovion Pharmaceuticals Main Business
Table 76. Sunovion Pharmaceuticals Latest Developments
Table 77. CHIESI Farmaceutici Details, Company Type, Chronic Obstructive Pulmonary Disease (COPD) Treatment Area Served and Its Competitors
Table 78. CHIESI Farmaceutici Chronic Obstructive Pulmonary Disease (COPD) Treatment Product Offered
Table 79. CHIESI Farmaceutici Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. CHIESI Farmaceutici Main Business
Table 81. CHIESI Farmaceutici Latest Developments
Table 82. Orion Corporation Details, Company Type, Chronic Obstructive Pulmonary Disease (COPD) Treatment Area Served and Its Competitors
Table 83. Orion Corporation Chronic Obstructive Pulmonary Disease (COPD) Treatment Product Offered
Table 84. Orion Corporation Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 85. Orion Corporation Main Business
Table 86. Orion Corporation Latest Developments
Table 87. ?Mylan Details, Company Type, Chronic Obstructive Pulmonary Disease (COPD) Treatment Area Served and Its Competitors
Table 88. ?Mylan Chronic Obstructive Pulmonary Disease (COPD) Treatment Product Offered
Table 89. ?Mylan Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 90. ?Mylan Main Business
Table 91. ?Mylan Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Chronic Obstructive Pulmonary Disease (COPD) Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Chronic Obstructive Pulmonary Disease (COPD) Treatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Chronic Obstructive Pulmonary Disease (COPD) Treatment Sales Market Share by Country/Region (2024)
Figure 8. Chronic Obstructive Pulmonary Disease (COPD) Treatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Market Share by Type in 2024
Figure 10. Chronic Obstructive Pulmonary Disease (COPD) Treatment in Hospital
Figure 11. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market: Hospital (2020-2025) & ($ millions)
Figure 12. Chronic Obstructive Pulmonary Disease (COPD) Treatment in Clinic
Figure 13. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market: Clinic (2020-2025) & ($ millions)
Figure 14. Chronic Obstructive Pulmonary Disease (COPD) Treatment in Retail Pharmacies
Figure 15. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market: Retail Pharmacies (2020-2025) & ($ millions)
Figure 16. Chronic Obstructive Pulmonary Disease (COPD) Treatment in Other
Figure 17. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market: Other (2020-2025) & ($ millions)
Figure 18. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Market Share by Application in 2024
Figure 19. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Market Share by Player in 2024
Figure 20. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Market Share by Region (2020-2025)
Figure 21. Americas Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size 2020-2025 ($ millions)
Figure 22. APAC Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size 2020-2025 ($ millions)
Figure 23. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size 2020-2025 ($ millions)
Figure 25. Americas Chronic Obstructive Pulmonary Disease (COPD) Treatment Value Market Share by Country in 2024
Figure 26. United States Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Market Share by Region in 2024
Figure 31. APAC Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Market Share by Type (2020-2025)
Figure 32. APAC Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Market Share by Application (2020-2025)
Figure 33. China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 37. India Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Market Share by Country in 2024
Figure 40. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Market Share by Type (2020-2025)
Figure 41. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Market Share by Application (2020-2025)
Figure 42. Germany Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 43. France Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size 2026-2031 ($ millions)
Figure 56. APAC Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size 2026-2031 ($ millions)
Figure 57. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size 2026-2031 ($ millions)
Figure 59. United States Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size 2026-2031 ($ millions)
Figure 60. Canada Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size 2026-2031 ($ millions)
Figure 61. Mexico Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size 2026-2031 ($ millions)
Figure 62. Brazil Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size 2026-2031 ($ millions)
Figure 63. China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size 2026-2031 ($ millions)
Figure 64. Japan Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size 2026-2031 ($ millions)
Figure 65. Korea Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size 2026-2031 ($ millions)
Figure 67. India Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size 2026-2031 ($ millions)
Figure 68. Australia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size 2026-2031 ($ millions)
Figure 69. Germany Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size 2026-2031 ($ millions)
Figure 70. France Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size 2026-2031 ($ millions)
Figure 71. UK Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size 2026-2031 ($ millions)
Figure 72. Italy Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size 2026-2031 ($ millions)
Figure 73. Russia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size 2026-2031 ($ millions)
Figure 74. Egypt Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size 2026-2031 ($ millions)
Figure 75. South Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size 2026-2031 ($ millions)
Figure 76. Israel Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size 2026-2031 ($ millions)
Figure 77. Turkey Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size 2026-2031 ($ millions)
Figure 78. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size 2026-2031 ($ millions)